Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 38 Suppl 2, 45-9

Therapeutic Challenges of Urosepsis

Affiliations
Review

Therapeutic Challenges of Urosepsis

F M E Wagenlehner et al. Eur J Clin Invest.

Abstract

Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a community or nosocomial acquired urinary tract infection (UTI). The underlying UTI is almost exclusively a complicated one with involvement of parenchymatous urogenital organs (e.g. kidneys, prostate). In urosepsis, as in other types of sepsis, the severity of sepsis depends mostly upon the host response. The treatment of urosepsis comprises four major aspects: Early goal directed therapy, early optimal pharmacodynamic exposure to antimicrobials, early control of the complicating factor in the urinary tract and specific sepsis therapy. Following these prerequisites there appear two major challenges that need to be addressed: Firstly, time from admission to therapy is critical; the shorter the time to effective treatment, the higher the success rate. This aspect has to become incorporated into the organisational process. Secondly, adequate initial antibiotic therapy has to be insured. This goal implies however, a wide array of measures to ensure rational antibiotic policy. Both challenges are best targeted if an interdisciplinary approach at any level of the process is established, encompassing urologists, intensive care specialists, radiologists, microbiologists and clinical pharmacologists working tightly together at any time.

Similar articles

  • Urosepsis--from the View of the Urologist
    FM Wagenlehner et al. Int J Antimicrob Agents 38 Suppl, 51-7. PMID 21993485. - Review
    Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a community-or nosocomial-acquired urinary tract infection (UTI). The underlying UTI is …
  • Optimal Management of Urosepsis From the Urological Perspective
    FM Wagenlehner et al. Int J Antimicrob Agents 30 (5), 390-7. PMID 17728107. - Review
    Urosepsis in adults comprises approximately 25% of all sepsis cases and in most cases is due to complicated urinary tract infections (UTIs). In this paper we review the o …
  • Pharmacokinetic Characteristics of Antimicrobials and Optimal Treatment of Urosepsis
    FM Wagenlehner et al. Clin Pharmacokinet 46 (4), 291-305. PMID 17375981. - Review
    Urosepsis accounts for approximately 25% of all sepsis cases and may develop from a community-acquired or nosocomial urinary tract infection (UTI). Nevertheless, the unde …
  • Diagnosis and Management for Urosepsis
    FM Wagenlehner et al. Int J Urol 20 (10), 963-70. PMID 23714209. - Review
    Urosepsis is defined as sepsis caused by a urogenital tract infection. Urosepsis in adults comprises approximately 25% of all sepsis cases, and is in most cases due to co …
  • [Rational Antibiotic Therapy of Urinary Tract Infections]
    FM Wagenlehner et al. Med Monatsschr Pharm 31 (10), 385-90; quiz 391-2. PMID 18972869. - Review
    Rational antibiotic therapy of urinary tract infections Urinary tract infections (UTI) are frequent infections in the outpatient and nosocomial setting. Generally UTI can …
See all similar articles

Cited by 19 PubMed Central articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback